Search Results - "Fredersdorf, S"

Refine Results
  1. 1

    Lone atrial fibrillation as a positive predictor of left atrial volume reduction following ablation of atrial fibrillation by Fredersdorf, Sabine, Ucer, Ekrem, Jungbauer, Carsten, Dornia, Christian, Eglmeier, Julia, Eissnert, Christoph, Hamer, Okka W, Weber, Stefan, Arzt, Michael, von Bary, Christian

    Published in Europace (London, England) (01-01-2014)
    “…We investigated predictors of left atrial volume reduction (LAVR) in patients with atrial fibrillation (AF) undergoing AF ablation. Sixty patients with AF…”
    Get full text
    Journal Article
  2. 2

    Assessment of the anatomic regurgitant orifice in aortic regurgitation: a clinical magnetic resonance imaging study by Debl, K, Djavidani, B, Buchner, S, Heinicke, N, Fredersdorf, S, Haimerl, J, Poschenrieder, F, Feuerbach, S, Riegger, G A J, Luchner, A

    Published in Heart (British Cardiac Society) (01-03-2008)
    “…The aim of our study was to determine whether planimetry of the anatomic regurgitant orifice (ARO) in patients with aortic regurgitation (AR) by magnetic…”
    Get more information
    Journal Article
  3. 3

    Increased aldosterone levels in a model of type 2 diabetes mellitus by Fredersdorf, S, Endemann, D H, Luchner, A, Heitzmann, D, Ulucan, C, Birner, C, Schmid, P, Stoelcker, B, Resch, M, Muders, F, Riegger, G A J, Weil, J

    “…Aldosterone is an important mediator of cardiovascular and renal remodeling. Type II diabetes mellitus leads to renal and cardiac end organ damage. We…”
    Get more information
    Journal Article
  4. 4

    Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure by Schneider, H.-J., Husser, O., Rihm, M., Fredersdorf, S., Birner, C., Dhein, S., Muders, F., Jeron, A., Goegelein, H., Riegger, G. A., Luchner, A.

    “…Congestive heart failure (CHF) is often associated with atrial fibrillation. The safety of many antiarrhythmic drugs in CHF is limited by proarrhythmic…”
    Get full text
    Journal Article
  5. 5
  6. 6

    P5696The first results from multicentre study of noninvasive epi-endocardial panoramic mapping of ventricular arrhythmias by Chmelevsky, M, Zubarev, S, Budanova, M, Potyagaylo, D, Uecer, E, Parreira, L, Treshkur, T, Fredersdorf, S, Adragao, P, Lebedev, D

    Published in European heart journal (01-10-2019)
    “…Abstract Background A noninvasive epi-endocardial panoramic mapping is a promising ECG Imaging technology alternative to catheter-based invasive methods. Some…”
    Get full text
    Journal Article
  7. 7
  8. 8

    H008: Methotrexate fails to suppress cardiac cytokine induction in pressure overload hypertrophy in rats by Jeron, A., Fredersdorf, S., Straub, R., Riegger, Günter A.J., Muders, F.

    Published in American journal of hypertension (01-04-2000)
    “…Elevated plasma levels of IL-6 and IL-1b were found in patients with heart failure and left ventricular hypertrophy (LVH) and correlated with poor outcome…”
    Get full text
    Journal Article
  9. 9

    Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues by Fredersdorf, S, Milne, AW, Hall, PA, Lu, X

    Published in The American journal of pathology (01-03-1996)
    “…As a universal inhibitor of cyclin-dependent kinases and one of the target genes of the tumor suppresser p53, p21Waf1/Cip1 can act as a tumor suppresser…”
    Get full text
    Journal Article
  10. 10

    A unique access for the ablation catheter to treat electrical storm in a patient with extracorporeal life support by Ücer, Ekrem, Fredersdorf, Sabine, Jungbauer, Carsten, Debl, Kurt, Philipp, Alois, Amann, Matthias, Holzamer, Andreas, Keyser, Andreas, Hilker, Michael, Luchner, Andreas, Schmid, Christof, Riegger, Günter, Endemann, Dierk

    Published in Europace (London, England) (01-02-2014)
    “…Extracorporeal membrane oxygenation (ECMO) is a very effective bridging therapy in patients with cardiogenic shock. To perform coronary angiography in these…”
    Get full text
    Journal Article
  11. 11

    E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction by Hsieh, J K, Fredersdorf, S, Kouzarides, T, Martin, K, Lu, X

    Published in Genes & development (15-07-1997)
    “…E2F1 overexpression has been shown to induce apoptosis in cooperation with p53. Using Saos-2 cells, which are null for p53 and lack functional Rb, we have…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Zim17, a Novel Zinc Finger Protein Essential for Protein Import into Mitochondria by Burri, Lena, Vascotto, Katherine, Fredersdorf, Steffen, Tiedt, Ralph, Hall, Michael N., Lithgow, Trevor

    Published in The Journal of biological chemistry (26-11-2004)
    “…Translocation of precursor proteins across the mitochondrial membranes requires the coordinated action of multisubunit translocases in the outer and inner…”
    Get full text
    Journal Article
  14. 14

    Secondary prevention implantable cardioverter-defibrillator (ICD) therapy in octogenarians: effective and safe by Hauck, C, Schober, A D, Schober, A L, Fredersdorf-Hahn, S, Hubauer, U, Keyser, A, Maier, L S, Jungbauer, C G, Uecer, E

    Published in European heart journal (12-10-2021)
    “…Abstract Aims Implantable cardioverter-defibrillator is well established for secondary prevention, but there is a lack of studies showing efficacy and safety…”
    Get full text
    Journal Article
  15. 15

    Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats by Fredersdorf, Sabine, Thumann, Christian, Ulucan, Coskun, Griese, Daniel P., Luchner, Andreas, Riegger, Günter A.J., Kromer, Eckhard P., Weil, Joachim

    Published in Cardiovascular pathology (2004)
    “…Heart failure is known to be a complication of insulin-dependent (IDDM) and noninsulin-dependent diabetes mellitus (NIDDM) even in the absence of coronary…”
    Get full text
    Journal Article
  16. 16

    P2873Novel ICD therapy reduction programming in primary and secondary prevention: reduced mortality and ICD-therapies in a real-life cohort by Schober, A D, Schober, A L, Uecer, E, Hubauer, U, Stadler, S, Fredersdorf-Hahn, S, Seegers, J, Maier, L S, Jungbauer, C G

    Published in European heart journal (01-10-2019)
    “…Abstract Background Implantable cardioverter defibrillator therapy (ICD), with or without combined cardiac resynchronization therapy, has been demonstrated to…”
    Get full text
    Journal Article
  17. 17

    Early onset of chondroitin sulfate and osteopontin expression in angiotensin ii-dependent left ventricular hypertrophy by Rothermund, Lars, Kreutz, Reinhold, Kossmehl, Peter, Fredersdorf, Sabine, Shakibaei, Mehdi, Schulze-Tanzil, Gundula, Paul, Martin, Grimm, Daniela

    Published in American journal of hypertension (01-07-2002)
    “…Chondroitin sulfate proteoglycan (CSPG) is expressed during embryonic heart development and osteopontin (OPN) is an important mediator of the profibrotic…”
    Get full text
    Journal Article
  18. 18

    Extracellular Matrix Proteins in Cardiac Fibroblasts Derived from Rat Hearts with Chronic Pressure Overload: Effects of Beta-receptor Blockade by Grimm, Daniela, Huber, Michaela, Jabusch, Hans C, Shakibaei, Mehdi, Fredersdorf, Sabine, Paul, Martin, Riegger, Günter A.J, Kromer, Eckhard P

    “…Left ventricular hypertrophy (LVH) is accompanied by progressive accumulations of extracellular matrix proteins. They are produced predominantly by cardiac…”
    Get full text
    Journal Article
  19. 19

    Norepinephrine upregulates vascular endothelial growth factor in rat cardiac myocytes by a paracrine mechanism by WEIL, Joachim, BENNDORF, Ralf, FREDERSDORF, Sabine, GRIESE, Daniel P, ESCHENHAGEN, Thomas

    Published in Angiogenesis (London) (2003)
    “…Norepinephrine has growth-promoting effects in cardiac myocytes. The present study in cultured neonatal rat cardiac myocytes tested the hypothesis that…”
    Get full text
    Journal Article
  20. 20

    Experimental diabetes and left ventricular hypertrophy: Effects of beta-receptor blockade by Grimm, Daniela, Jabusch, Hans C., Kossmehl, Peter, Huber, Michaela, Fredersdorf, Sabine, Griese, Daniel P., Krämer, Bernhard K., Kromer, Eckhard P.

    Published in Cardiovascular pathology (01-07-2002)
    “…Background: Left ventricular hypertrophy involves growth of cardiomyocytes, as well as remodeling of extracellular matrix proteins (ECMPs). Several metabolic…”
    Get full text
    Journal Article